Selecting Dose Schedules at Equal Daily Dose

Why the schedule matters at an equal daily dose

Two regimens can deliver the same total amount of drug each day and still produce different concentration-time profiles. A larger dose given less often generally produces a higher peak and a lower trough than smaller, more frequent doses. Whether this matters depends on the relationship between exposure over time and the desired clinical effects: efficacy may require concentrations to remain adequate between doses, while toxicity may be related to high concentrations or peaks.

A comparison of schedules is therefore not simply a comparison of daily milligrams. It is a prediction about the concentrations that those milligrams produce over time, followed by an interpretation in light of the relevant efficacy and safety criteria. The calculations below use an intentionally simple pharmacokinetic model; the assumptions should be checked before applying its predictions to a real regimen.

This idealization treats each dose as entering the systemic circulation instantaneously after accounting for \(F\). Real oral absorption takes time, and formulations may release drug at different rates. Those features can alter the peak and the shape of the profile, so the bolus calculations are a comparison framework rather than a substitute for an appropriate model.

Steady-state peak, trough, and AUC

Immediately after a dose, the concentration rises by \(F D_\tau/V\). During the following \(\tau\) hours, it declines exponentially. If \(C_{\max}\) is the concentration just after a dose and \(C_{\min}\) is the concentration just before the next dose, then \(C_{\min}=C_{\max}e^{-k\tau}\). At steady state, the concentration just before a dose equals the preceding interval’s trough. Adding the new dose increment to that residual concentration gives the steady-state peak.

Rearranging gives the steady-state peak and trough. The same result can be written in terms of \(D_{\mathrm{day}}\) for a fixed daily dose.

The ratio \(C_{\max}/C_{\min}=e^{k\tau}\) shows directly that, for fixed \(k\), a longer interval produces a wider peak-to-trough ratio. The absolute peak and trough also depend on the dose per administration, which changes with the interval when the daily dose is held fixed.

The AUC result follows because, over a complete interval at steady state, the amount entering the systemic circulation is \(F D_\tau\), while the total amount eliminated equals the amount entering. With clearance \(CL\), the interval AUC is systemic amount divided by clearance: \(AUC_\tau=F D_\tau/CL\). Dividing by \(\tau\), and substituting \(D_\tau=D_{\mathrm{day}}\tau/24\), gives the daily average:

This is an average over time, not a promise that concentrations are constant. AUC alone may be insufficient when the effect depends on maintaining a trough, avoiding a high peak, or on a more complex exposure measure.

Use the profile to assess efficacy and peak-related toxicity

Concentration thresholds can make the schedule comparison concrete when they are clinically justified. A minimum effective concentration is a target for maintaining adequate exposure; a maximum tolerated concentration can represent a peak-related safety constraint. Such thresholds are simplifications: a concentration-response relationship may be gradual, vary between people, or depend on the timing and duration of exposure. They should not be inferred from the formulas alone.

The decision should compare each predicted profile with the relevant criteria, rather than selecting the schedule with the highest peak or assuming that an equal AUC guarantees equal clinical effects. The following example applies a trough requirement and a peak ceiling to the hypothetical profiles already calculated.

The formulas also clarify why shorter intervals often improve trough coverage while reducing peak exposure at an equal daily dose. Dividing the daily amount into more administrations reduces \(D_\tau\), and the concentration has less time to decline before the next dose. The net profile must still be calculated: the change is not captured by dose size alone.

Assumptions, diagnostics, and alternatives

The comparison is most defensible when pharmacokinetics are dose proportional over the relevant range, absorption and bioavailability are stable, the patient follows the schedule, and the evaluated concentrations represent steady state. It also assumes that a one-compartment, first-order elimination profile is adequate. If absorption is prolonged, peaks are not instantaneous; if disposition is nonlinear, equal daily amounts need not produce equal AUC; and if clearance or bioavailability changes over time, a single fixed-parameter profile can mislead.

Useful checks include comparing observed concentration-time data with the predicted shape, verifying that samples were collected at interpretable times relative to dosing, and checking whether the estimated parameters are plausible for the population and formulation. Unexpected accumulation, inconsistent peaks or troughs, or systematic prediction errors can indicate incorrect dose timing, missed doses, model misspecification, time-varying pharmacokinetics, or variability not represented by the typical profile. A population-average prediction should not be treated as a guarantee for each individual.

Alternative comparisons answer different questions. Comparing equal daily doses asks how schedules redistribute the same administered amount over time. Comparing schedules at matched AUC focuses on average exposure; under linear pharmacokinetics this coincides with equal daily dose only when bioavailability is unchanged. Matching troughs or peaks instead may require different daily amounts and therefore does not hold total dose constant. A model with absorption or a more complex disposition structure may be needed to compare oral formulations or infusion schedules; the simple bolus equations should not be applied unchanged to those inputs.

Common mistake and practical interpretation

• Wrong reasoning: “The daily dose and AUC are equal, so the schedules should have the same efficacy and toxicity.”
• Correction: Equal AUC under linear pharmacokinetics establishes equal average exposure, not equal concentration at each time. If outcome depends on trough coverage or peak concentration, schedules can differ even when daily AUC is identical.
• Wrong reasoning: “The longer interval always gives a clinically unacceptable profile.”
• Correction: A longer interval produces greater fluctuation in this model, but whether that matters depends on the drug’s exposure-response and safety relationships, the required targets, and patient-specific parameters.

In practice, schedule selection is a constrained comparison. First predict the profiles under an appropriate PK model; then evaluate them against justified efficacy and safety criteria; finally consider implementation and uncertainty. If the assumptions are weak or the predicted margins are narrow, a more suitable model or additional evidence may be needed before choosing a schedule.